NEW TULAMYCIN® K, ANTIBIOTIC - ANTI-INFLAMMATORY ASSOCIATION FOR RESPIRATORY PROBLEMS IN A SINGLE DOSE
Posted on 31/03/2022
AGROVET MARKET®, a leader in pharmaceutical product innovation, presents a new PREMIUM product: TULAMYCIN® K, an antibiotic-anti-inflammatory dose combination based on a semi-synthetic macrolide of the triamilide subclass and a single powerful non-steroidal anti-inflammatory drug.
TULAMYCIN® K is characterized by being a product that provides a long-acting antibiotic with great penetration, accumulation and permanence in the respiratory tissue. Its rapid absorption, high bioavailability and excellent distribution reach therapeutic concentrations effectively against bacteria sensitive to tulathromycin, while the anti-inflammatory, analgesic and antipyretic action of ketoprofen in its formula allows it to reduce the clinical symptoms of animals treated in few hours.
Tulathromycin has proven to be the most advantageous option against the main bacterial agents involved in bovine respiratory disease (BRD), including Mycoplasma bovis. Likewise, it has shown superior efficacy for BRD compared to tilmicosin, enrofloxacin, and florfenicol.
TULAMYCIN® K is intended for use in cattle, pigs, sheep and South American camelids. Being its application subcutaneously in cattle.
For more information about the Agrovet Market product portfolio, we recommend you visit our website: www.agrovetmarket.com